{"schema_version":"secwatch.filing_event.v1","accession":"0000031791-25-000003","form_type":"8-K","ticker":"RVTY","cik":"0000031791","company_name":"REVVITY, INC.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.950084+00:00","generated_at":"2026-05-28T04:06:06.049996+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Revvity provides preliminary Q4 revenue ~$730M, 6% organic growth; EPS guidance reaffirmed","bullets":["Q4 preliminary revenue ~$730M; reported growth ~5%, organic ~6% vs. prior year.","Full-year 2024 adjusted EPS expected to meet or exceed guidance provided Nov 4, 2024.","Q4 and full-year 2024 results to be released Jan 31, 2025; conference call at 8am ET.","CEO Prahlad Singh to present at J.P. Morgan Healthcare Conference on Jan 13, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000031791-25-000003","json":"https://secwatch.observer/filing/0000031791-25-000003.json","markdown":"https://secwatch.observer/filing/0000031791-25-000003.md","text":"https://secwatch.observer/filing/0000031791-25-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/31791/000003179125000003/0000031791-25-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/31791/000003179125000003/pki-20250112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:06:06.049996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}